Unraveling complement activation profiles on endothelial cells in healthy donors using an ex vivo model
Clinical and Experimental Immunology · 2026
DOI: 10.1093/cei/uxaf082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2026. Verfasst von Anna Duval und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France. Hauptthemen laut MEDLINE: Complement Activation, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Functional approaches to properly examine individual’s susceptibility to complement dysregulation are limited. We assessed ex vivo complement activation induced by sera from 38 healthy donors on resting microvascular endothelial cells with or without complement dysregulation (OX-24 monoclonal antibody). Following incubation, immunofluorescence was used to quantify membrane-bound C3b/iC3b and C5b-9 with a computer-assisted method (H-score). C3a and C5a anaphylatoxins were quantified in supernatants by ELISA. Genetic sequencing of 32 donors was also performed to identify variants in alternative pathway genes. Elevated complement deposition was defined by H-scoreC3c > 50 and/or H-scoreC5b-9 > 30. Combined analysis of C3b/iC3b and C5b-9 deposition in 35 donors showed that one donor (2.8%) had an isolated increase in C3b/iC3b deposits, three (8.6%) had an isolated increase in C5b-9 deposits, and one (2.8%) had both increased C3b/iC3b and C5b-9 deposition. Genetic analysis revealed three heterozygous rare/low frequency missense variants in CFH (p.N1050Y, p.R1210C) and CFI (p.A76G) in 3/5 donors with increased complement deposition. This model revealed distinct patterns of complement activation among healthy individuals and identified a genetic basis for dysregulation in three cases. This assay offers a promising tool to study complement activity and its mechanisms in research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
- Department of Nephrology Dialysis and Transplantation, University Hospital of Strasbourg, Strasbourg, France.
- Service d'immunologie biologique, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
- Service de Néphrologie, Hôpital Européen Georges Pompidou, Paris, France.
ORCID-Profile: Anna Duval, Lubka Roumenina
Förderung
- Fondation pour la Recherche Médicale
Zitieren
APA
Duval, A., Meuleman, M. S., Grunenwald, A., Vieira-Martins, P., Dragon-Durey, M. A., Chauvet, S., Roumenina, L., Caillard, S., & Frémeaux-Bacchi, V. (2026). Unraveling complement activation profiles on endothelial cells in healthy donors using an ex vivo model. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf082
Vancouver
Duval A, Meuleman MS, Grunenwald A, Vieira-Martins P, Dragon-Durey MA, Chauvet S, et al. Unraveling complement activation profiles on endothelial cells in healthy donors using an ex vivo model. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxaf082
BibTeX
@article{Duval2026,
author = {Duval, Anna and Meuleman, Marie-Sophie and Grunenwald, Anne and Vieira-Martins, Paula and Dragon-Durey, Marie-Agnès and Chauvet, Sophie and Roumenina, Lubka and Caillard, Sophie and Frémeaux-Bacchi, Véronique},
title = {Unraveling complement activation profiles on endothelial cells in healthy donors using an ex vivo model},
journal = {Clinical and Experimental Immunology},
year = {2026},
doi = {10.1093/cei/uxaf082}
}
EUVIMED